Key Financial Data Of Group

Astellas Pharma Inc. - Filing #7736700

Concept As at
2017-06-30
2017-04-01 to
2017-06-30
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-06-30
2016-04-01 to
2016-06-30
Key financial data of group
Business results of group
Revenue
322,571,000,000 JPY
1,311,665,000,000 JPY
337,752,000,000 JPY
Profit (loss) before tax
48,471,000,000 JPY
281,769,000,000 JPY
93,184,000,000 JPY
Profit (loss), attributable to owners of parent
42,468,000,000 JPY
218,701,000,000 JPY
66,613,000,000 JPY
Comprehensive income, attributable to owners of parent
83,520,000,000 JPY
174,644,000,000 JPY
-34,006,000,000 JPY
Equity attributable to owners of parent
1,319,652,000,000 JPY
1,271,810,000,000 JPY
1,190,527,000,000 JPY
Total assets
1,901,237,000,000 JPY
1,820,901,000,000 JPY
1,693,626,000,000 JPY
Basic earnings (loss) per share
20.57
103.69
31.35
Diluted earnings (loss) per share
20.54
103.55
31.31
Ratio of owners' equity to gross assets
0.694 xbrli:pure
0.698 xbrli:pure
0.703 xbrli:pure
Cash flows from (used in) operating activities
59,492,000,000 JPY
235,612,000,000 JPY
18,150,000,000 JPY
Cash flows from (used in) investing activities
-56,026,000,000 JPY
-73,383,000,000 JPY
-6,583,000,000 JPY
Cash flows from (used in) financing activities
-36,154,000,000 JPY
-166,153,000,000 JPY
-35,237,000,000 JPY
Cash and cash equivalents
314,417,000,000 JPY
340,923,000,000 JPY
311,985,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.